- Home
- Publications
- Publication Search
- Publication Details
Title
Up-Date on Diabetic Nephropathy
Authors
Keywords
-
Journal
Life-Basel
Volume 12, Issue 8, Pages 1202
Publisher
MDPI AG
Online
2022-08-09
DOI
10.3390/life12081202
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Advances in Diabetic Nephropathy
- (2022) Hanny Sawaf et al. Journal of Clinical Medicine
- Antioxidant Roles of SGLT2 Inhibitors in the Kidney
- (2022) Carmen Llorens-Cebrià et al. Biomolecules
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- (2021) Hertzel C. Gerstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
- (2021) Hong Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?
- (2020) Michele Provenzano et al. Biomolecules
- The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?
- (2020) Anne C. Hesp et al. KIDNEY INTERNATIONAL
- Time for clinical decision support systems tailoring individual patient therapy to improve renal and cardiovascular outcomes in diabetes and nephropathy
- (2020) Dick de Zeeuw et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile
- (2020) Michele Provenzano et al. PLoS One
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- (2020) George L. Bakris et al. NEW ENGLAND JOURNAL OF MEDICINE
- 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- Selective endothelin A receptor antagonism in patients with proteinuric chronic kidney disease
- (2020) Michele Provenzano et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes
- (2019) Viktor Rotbain Curovic et al. DIABETES CARE
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- (2019) Hiddo J L Heerspink et al. LANCET
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarker panels associated with progression of renal disease in type 1 diabetes
- (2019) Marco Colombo et al. DIABETOLOGIA
- Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne’s Thread
- (2019) Anila Duni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetes
- (2019) Michael Kammer et al. KIDNEY INTERNATIONAL
- Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
- (2018) Katherine R Tuttle et al. Lancet Diabetes & Endocrinology
- Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988–2014
- (2018) Mohammed K Ali et al. Lancet Diabetes & Endocrinology
- Urinary kidney injury molecule-1 in renal disease
- (2018) Rafael N. Moresco et al. CLINICA CHIMICA ACTA
- A more tubulocentric view of diabetic kidney disease
- (2017) Letizia Zeni et al. JOURNAL OF NEPHROLOGY
- Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy
- (2017) Yong-Chao Qiao et al. MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus
- (2017) Martina Guthoff et al. Scientific Reports
- Comparison of symmetric dimethylarginine with creatinine, cystatin C and their eGFR equations as markers of kidney function
- (2016) Joe M. El-Khoury et al. CLINICAL BIOCHEMISTRY
- Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes
- (2016) José Antonio M. de Carvalho et al. CLINICAL BIOCHEMISTRY
- Is a reduction in albuminuria associated with renal and cardiovascular protection? Apost hocanalysis of the ALTITUDE trial
- (2016) H. J. L. Heerspink et al. DIABETES OBESITY & METABOLISM
- Podocyte injury and its consequences
- (2016) Michio Nagata KIDNEY INTERNATIONAL
- Urinary Retinol-Binding Protein: Relationship to Renal Function and Cardiovascular Risk Factors in Chronic Kidney Disease
- (2016) Maria Alice Muniz Domingos et al. PLoS One
- The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers
- (2015) Bauke Schievink et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Biomarkers of rapid chronic kidney disease progression in type 2 diabetes
- (2015) Helen C. Looker et al. KIDNEY INTERNATIONAL
- Soluble Urokinase Receptor and Chronic Kidney Disease
- (2015) Salim S. Hayek et al. NEW ENGLAND JOURNAL OF MEDICINE
- GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
- (2015) Ramu Adela et al. Journal of Diabetes Research
- Improved Survival and Renal Prognosis of Patients With Type 2 Diabetes and Nephropathy With Improved Control of Risk Factors
- (2014) Gudbjörg Andrésdóttir et al. DIABETES CARE
- Association of urinary RBP4 with insulin resistance, inflammation, and microalbuminuria
- (2014) Se Eun Park et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis
- (2014) H. Yilmaz et al. HERZ
- Autophagy in diabetic nephropathy
- (2014) Yan Ding et al. JOURNAL OF ENDOCRINOLOGY
- Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes
- (2014) S. Theilade et al. JOURNAL OF INTERNAL MEDICINE
- Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
- (2014) S. Ramakrishnan et al. Journal of Neuroimmune Pharmacology
- The potential for renoprotection with incretin-based drugs
- (2014) Tetsuhiro Tanaka et al. KIDNEY INTERNATIONAL
- ‘Progressive diabetic nephropathy. How useful is microalbuminuria?: contra’
- (2014) Richard J. MacIsaac et al. KIDNEY INTERNATIONAL
- Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
- (2013) E. Singer et al. Acta Physiologica
- Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients
- (2013) Marta Toni et al. DIABETOLOGIA
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Utility of Novel Biomarkers of Cardiovascular Stress
- (2012) Thomas J. Wang et al. CIRCULATION
- Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic Nephropathy
- (2012) S. S. Kim et al. DIABETES CARE
- Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes
- (2012) M. E. Hellemons et al. DIABETES CARE
- Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis
- (2012) F. He et al. DIABETOLOGIA
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Renin-Angiotensin-Aldosterone System in Podocytes
- (2012) Dirk Oliver Wennmann et al. SEMINARS IN NEPHROLOGY
- Effect of Eplerenone, a Selective Aldosterone Blocker, on the Development of Diabetic Nephropathy in Type 2 Diabetic Rats
- (2012) Jae Hee Ahn et al. Diabetes & Metabolism Journal
- Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and MicroalbuminuriaAn Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications CohortMicroalbuminuria Outcomes in Type 1 Diabetes
- (2011) Ian H. de Boer ARCHIVES OF INTERNAL MEDICINE
- Retinol-binding protein 4 : a possible role in cardiovascular complications
- (2011) Jogeswar Mohapatra et al. BRITISH JOURNAL OF PHARMACOLOGY
- Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes
- (2011) F. L. Nauta et al. DIABETES CARE
- Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration
- (2011) Wen-Jin Fu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease
- (2011) G. Mayer NEPHROLOGY DIALYSIS TRANSPLANTATION
- Early Urinary Markers of Diabetic Kidney Disease: A Nested Case-Control Study From the Diabetes Control and Complications Trial (DCCT)
- (2010) Elizabeth F.O. Kern et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy
- (2010) M. Lajer et al. DIABETES CARE
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease
- (2010) Blai Coll et al. KIDNEY INTERNATIONAL
- Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes
- (2009) M L. Marcovecchio et al. ARCHIVES OF DISEASE IN CHILDHOOD
- The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential
- (2009) Hiroyuki Mori et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Design of Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D)
- (2009) L. F. Fried et al. Clinical Journal of the American Society of Nephrology
- Pathogenic perspectives for the role of inflammation in diabetic nephropathy
- (2009) Antonio Rivero et al. CLINICAL SCIENCE
- Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats
- (2009) Horacio Osorio et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Factors other than glomerular filtration rate affect serum cystatin C levels
- (2009) Lesley A. Stevens et al. KIDNEY INTERNATIONAL
- In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria
- (2009) Bruce A. Perkins et al. KIDNEY INTERNATIONAL
- SLC2A2 gene expression in kidney of diabetic rats is regulated by HNF-1α and HNF-3β
- (2009) H.S. Freitas et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
- (2008) J. M. Forbes et al. DIABETES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now